An update to our previous blog post: Mylan will pay $465 million in fines to settle claims brought by the U.S. Justice Department. In a rare instance of a corporation being the whistleblower, the drug company Sanofi first brought the matter to the U.S. Attorney’s office in 2014 because it was selling a competing drug. Sanofi will receive $38.7 million as its share of the recovery.